MX2017014666A - Metodos de inmunización contra clostridium difficile. - Google Patents

Metodos de inmunización contra clostridium difficile.

Info

Publication number
MX2017014666A
MX2017014666A MX2017014666A MX2017014666A MX2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A MX 2017014666 A MX2017014666 A MX 2017014666A
Authority
MX
Mexico
Prior art keywords
difficile
methods
cdt
purified
toxin
Prior art date
Application number
MX2017014666A
Other languages
English (en)
Inventor
Quemeneur Laurence
J Pietrobon Patricia
LONDONO-HAYES Patricia
HAUSER Steven
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of MX2017014666A publication Critical patent/MX2017014666A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Abstract

La descripción se relaciona generalmente al campo de vacunación terapéutica y/o protectora contra Clostridium difficile (C. difficile). Más específicamente, se relaciona a métodos para inmunizar un hospedero contra cepas C. difficile que expresan toxina binaria C. difficile (CDT) y cepas que no expresan CDT. Estos métodos involucran la administración a un hospedero de una composición inmunogénica que comprende Toxina A C. difficile purificada inactivada y Toxina B purificada. Las toxinas C. difficile purificadas se pueden derivar de una cepa C. difficile que no expresa CDT.
MX2017014666A 2015-05-15 2016-05-14 Metodos de inmunización contra clostridium difficile. MX2017014666A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562162357P 2015-05-15 2015-05-15
PCT/US2016/032568 WO2016187073A1 (en) 2015-05-15 2016-05-14 Methods for immunizing against clostridium difficile

Publications (1)

Publication Number Publication Date
MX2017014666A true MX2017014666A (es) 2018-02-09

Family

ID=56101790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014666A MX2017014666A (es) 2015-05-15 2016-05-14 Metodos de inmunización contra clostridium difficile.

Country Status (11)

Country Link
US (1) US20180110849A1 (es)
EP (1) EP3294330A1 (es)
JP (1) JP2018521967A (es)
KR (1) KR20180011784A (es)
CN (1) CN107847576A (es)
AU (1) AU2016263203A1 (es)
BR (1) BR112017024443A2 (es)
CA (1) CA2986025A1 (es)
IL (1) IL255592A (es)
MX (1) MX2017014666A (es)
WO (1) WO2016187073A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021506279A (ja) * 2017-12-13 2021-02-22 テキサス テック ユニヴァーシティー システムＴｅｘａｓ Ｔｅｃｈ Ｕｎｉｖｅｒｓｉｔｙ Ｓｙｓｔｅｍ 発情の早期開始を刺激し春機発動前後のイノシシ科動物の繁殖供用における必要労力を軽減するためのフェロモン組成物及び使用方法
EP3880240A4 (en) * 2018-11-16 2022-08-03 Matrivax, Inc. MULTI-COMPONENT CLOSTRIDIUM DIFFICILE VACCINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669520B2 (en) 2001-09-19 2003-12-30 United Microelectronics Corp. Method of fabricating an LC panel
CN105147611A (zh) 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
CA2699435A1 (en) 2007-09-14 2009-03-19 Sanofi Pasteur Biologics Co. Pharmaceutical compositions containing clostridium difficile toxoids a and b
AR089797A1 (es) 2012-01-27 2014-09-17 Merck Sharp & Dohme Vacunas contra clostridum difficile que comprenden toxinas recombinantes
GB201206070D0 (en) * 2012-04-04 2012-05-16 Health Prot Agency Clostridium difficile antigens
EP2968507A2 (en) * 2013-03-15 2016-01-20 Sanofi Pasteur, Inc. Toxoid, compositions and related methods

Also Published As

Publication number Publication date
JP2018521967A (ja) 2018-08-09
EP3294330A1 (en) 2018-03-21
KR20180011784A (ko) 2018-02-02
IL255592A (en) 2018-01-31
CA2986025A1 (en) 2016-11-24
WO2016187073A1 (en) 2016-11-24
AU2016263203A1 (en) 2017-11-30
US20180110849A1 (en) 2018-04-26
BR112017024443A2 (pt) 2018-10-23
CN107847576A (zh) 2018-03-27

Similar Documents

Publication Publication Date Title
MX351074B (es) Vacunas contra clostridium difficile que comprenden toxinas recombinantes.
MA39717A (fr) Procédés et compositions pour accroître le rapport des lymphocytes t effecteurs aux lymphocytes t régulateurs
JO3600B1 (ar) لقاحات مؤتلفة ل fmdv و استخداماتها
MX2018004598A (es) Cepas vacunales recombinantes de listeria y métodos para usar las mismas en la inmunoterapia contra el cáncer.
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2017004897A (es) Cepas vacunales recombinantes de listeria y metodos para usar las mismas en la inmunoterapia contra el cancer.
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
MX2016009072A (es) Fusion de antigenos micobacterianos heterooligomericos.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
MY191539A (en) Streptococcal vaccine
JOP20170022B1 (ar) لقاحات التهاب العين الفيروسي المهجنة المنقولة بواسطة اف ام دي في و استخداماتها
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
MX2021009105A (es) Toxinas apxia, apxiia y apxiiia inactivadas.
MX2018015506A (es) Vacuna contra virus de bronquitis infecciosa.
MX2018002901A (es) Proceso para preparar una vacuna tetravalente atenuada contra el dengue.
PH12017501795A1 (en) Pestivirus vaccines for congenital tremors
MX2017014666A (es) Metodos de inmunización contra clostridium difficile.
PH12017500419B1 (en) Recoded arbovirus and vaccines
MX2019011026A (es) Nueva vacuna de adn dirigida a pd-l1 para inmunoterapia de cancer.
MX2016002823A (es) Metodos y composiciones para vacunas vectorizadas virales.
TW201613952A (en) Cdca1-derived peptide and vaccine containing same
MY192535A (en) Method of using cistanche tubulosa extract for preparing drugs or food to protect eye cells
EP3852796A4 (en) VACCINE, METHOD OF VACCINATION AGAINST CLOSTRIDIUM DIFFICILE